Two-shot vaccine developed jointly between British university and British-Swedish drugmaker under scrutiny over possible links to blood clots
Actualités similaires
Agency says the shot is not associated with overall increased risks of blood clots, but could not rule out links to certain rare cases
Actualités similaires
Four vaccines may soon be in widespread use. The numbers are confusing, but all of them are keeping people from going to the hospital and dying
Actualités similaires
Top UN officials say of 128 million doses administered, more than three-quarters are in 10 rich countries, leaving much of the world at risk
Actualités similaires
Researchers say that, based on their trial, which involved about 20,000 people in Russia last fall, the vaccine is about 91 percent effective in preventing ...
Actualités similaires